Analyst has bullish outlook on AngioDynamics, Inc. (NASDAQ: ANGO)

Analysts now project that AngioDynamics will reach breakeven in 2028, with a modest profit of around US$700k expected that year.

AngioDynamics’ recent losses have narrowed from approximately US$34m to an estimated US$32m, indicating progress toward profitability.

An aggressive average revenue growth rate of around 56% per year is required to meet the projected profitability timeline.